A 2-Month Safety Follow-up Trial of Subjects From MannKind Protocols MKC-TI-009, MKC-TI-102, MKC-TI-103 and MKC-TI-030
A 2-Month Safety Follow-up Trial of Subjects From MannKind Protocols MKC-TI-009, MKC-TI-102, MKC-TI-103 and MKC-TI-030
The main purpose of the trial is to evaluate pulmonary function in subjects who had completed any one of the 4 MKC parent trials (MKC-TI-009, MKC-TI-102, MKC-TI-103, or MKC-TI-030) for an additional 2-month safety follow-up.
This was a 2-month safety follow-up study of subjects from MannKind protocols MKC-TI-009, MKC-TI-102, MKC-TI-103 and MKC-TI-030. No study medications were administered during this trial. The adverse event data included are for the combined Safety population irrespective of previous treatments in the parent trials.
Inclusion Criteria:
Exclusion Criteria:
Tuscon, Arizona 85712, United States
Garden Grove, California 92840, United States
Minneapolis, Minnesota 55455, United States
Wenatchee, Washington 98801, United States
Moscow, RUS 105229, Russia
Moscow, RUS 109240, Russia
Moscow, RUS 111399, Russia
Moscow, RUS 117593, Russia
Moscow, RUS 119435, Russia
Saint Petersburg, RUS 193012, Russia
Smolensk, RUS 214018, Russia